GLI1 and breast carcinoma: Ye et al. reported that miR-616-3p inhibited cell growth and mammosphere formation of breast cancer cells by suppressing GLI1 [22], while Yuan reported that miR-616-3p promoted breast cancer cell migration and invasion by targeting TIMP2 and regulating MMP signaling [23].